Latest debt-to-equity ratio

Aptevo Therapeutics Debt-to-equity ratio

Direct answer

Aptevo Therapeutics's debt-to-equity ratio is 69.67%.

The verified market snapshot reports 69.67%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 21, 2026.

Get free Aptevo Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Debt-to-equity ratio
69.67%